Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatmentGabrielli, Orazio ; Clarke, Lorne A ; Ficcadenti, Anna ; Santoro, Lucia ; Zampini, Lucia ; Volpi, Nicola ; Coppa, Giovanni VBMC medical genetics, 2016-03, Vol.17 (1), p.19-19, Article 19 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
13C-breath tests in the study of mitochondrial liver functionCandelli, M ; Cazzato, I A ; Zocco, M A ; Nista, E C ; Fini, L ; Armuzzi, A ; Camise, V ; Santoro, M ; Miele, L ; Grieco, A ; Gasbarrini, G ; Gasbarrini, AEuropean review for medical and pharmacological sciences, 2004-01, Vol.8 (1), p.23 [Periódico revisado por pares]ItalySem texto completo |
|
3 |
Material Type: Artigo
|
34P Heterogeneous response to immune checkpoint inhibitors in metastatic melanoma patients: Assessment of lesion-level response with 18F-FDG PET/CTStrašek, K. ; Huff, D. ; N.Hribernik ; Zurbriggen, L. ; Doma, A. ; Lawrence, E.M. ; Studen, A. ; Ma, V.T. ; Fernandes, V. Santoro ; Albertini, M.R. ; Zevnik, K. ; Škalič, K. ; Reberšek, M. ; Jeraj, R.Immuno-oncology technology, 2023-12, Vol.20, p.100503, Article 100503 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
6062 NGR-hTNF, a vascular targeting agent (VTA), administered as single agent in patients (pts) with colorectal cancer (CRC) failing standard regimens: a phase II studyRimassa, L ; Santoro, A ; Sobrero, A.F ; Sclafani, F ; Gregorc, V ; Andretta, V ; Tronconi, M.C ; Cappio, F. Caligaris ; Lambiase, A ; Bordignon, CEuropean journal of cancer supplements, 2009, Vol.7 (2), p.340-340 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
6556 POSTER Prognostic role of standard uptake value (SUV) on positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM)Ceresoli, G.L. ; Pinto, C. ; Selvaggi, G. ; Zucali, P.A. ; Mutri, V. ; Salamina, S. ; Fanti, S. ; Martoni, A. ; Scagliotti, G.V. ; Santoro, A.European journal of cancer supplements, 2007-09, Vol.5 (4), p.374-375 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
6556 POSTER Prognostic role of standard uptake value (SUV) on positron emission tomography with18 F-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM)Ceresoli, G.L ; Pinto, C ; Selvaggi, G ; Zucali, P.A ; Mutri, V ; Salamina, S ; Fanti, S ; Martoni, A ; Scagliotti, G.V ; Santoro, AEuropean journal of cancer supplements, 2007, Vol.5 (4), p.374-375 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
6617 Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC)Santoro, A ; Citterio, G ; Pressiani, T ; Gregorc, V ; Rimassa, L ; De Braud, F.G ; Rossoni, G ; Cappio, F. Caligaris ; Lambiase, A ; Bordignon, CEuropean journal of cancer supplements, 2009, Vol.7 (2), p.395-395 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
9011 NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II studyGregorc, V ; Ceresoli, G.L ; Zucali, P.A ; De Braud, F.G ; Bajetta, E ; Santoro, A ; Viganò, M.G ; Cappio, F. Caligaris ; Lambiase, A ; Bordignon, CEuropean journal of cancer supplements, 2009, Vol.7 (2), p.509-509 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
9430 Efficacy and toxicity of sorafenib in patients with advanced soft tissue sarcoma failing anthracycline-based chemotherapyBertuzzi, A ; Stroppa, E ; Secondino, S ; Zucali, P ; Quagliuolo, V ; Pedrazzoli, P ; Comandone, A ; Basso, U ; Parra, H. Soto ; Santoro, AEuropean journal of cancer supplements, 2009, Vol.7 (2), p.599-599 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
98P Cancers of unknown primary (CUP): Real-world clinical outcomes and genomic analysis at the European Institute of OncologyBielo, L. Boscolo ; Belli, C. ; Crimini, E. ; Repetto, M. ; Rocco, E. Guerini ; Ascione, L. ; Santoro, C. ; Pellizzari, G. ; Fuorivia, V. ; Barberis, M. ; Curigliano, G.ESMO open, 2024-02, Vol.9 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |